|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Investments, at fair value | |||||||||||||
| Non-controlled/non-affiliate company investments | |||||||||||||
| Non-controlled affiliate company investments | |||||||||||||
| Total investments, at fair value | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Cash | |||||||||||||
| Cash equivalents | |||||||||||||
| Foreign currencies (cost of $5,377 and $4,645, respectively) | |||||||||||||
| Restricted cash and cash equivalents | |||||||||||||
| Cash collateral held for interest rate swaps | |||||||||||||
| Restricted cash | |||||||||||||
| Restricted cash equivalents | |||||||||||||
| Interest receivable | |||||||||||||
| Receivable for investments | |||||||||||||
| Deferred offering costs | |||||||||||||
| Net unrealized appreciation on derivatives | |||||||||||||
| Other assets | |||||||||||||
| Total Assets | |||||||||||||
| Liabilities | |||||||||||||
| Debt | |||||||||||||
| Less unamortized debt issuance costs | |||||||||||||
| Debt less unamortized debt issuance costs | |||||||||||||
| Other short-term borrowings | |||||||||||||
| Interest payable | |||||||||||||
| Distributions payable | |||||||||||||
| Management and incentive fees payable | |||||||||||||
| Management and income incentive fees payable | |||||||||||||
| Payable for investments purchased | |||||||||||||
| Accrued trustee fees | |||||||||||||
| Net unrealized depreciation on derivatives | |||||||||||||
| Accounts payable and other liabilities | |||||||||||||
| Total Liabilities | |||||||||||||
| Net Assets | |||||||||||||
| Preferred shares, par value $0.001 per share, 1,000,000 shares authorized, zero shares issued and outstanding as of June 30, 2026 and September 30, 2025. | |||||||||||||
| Common shares, par value $0.01 per share, unlimited shares authorized, 185,108,156 and 161,326,430 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively. | |||||||||||||
| Paid in capital in excess of par | |||||||||||||
| Distributable earnings (loss) | |||||||||||||
| Common Class I | |||||||||||||
| Common Class S | |||||||||||||
| Total Net Assets | |||||||||||||
| Number of common shares outstanding (in shares) | |||||||||||||
| Common Class I | |||||||||||||
| Common Class S | |||||||||||||
| Total number of common shares outstanding (in shares) | |||||||||||||
| Net asset value per common share (in dollars per share) | |||||||||||||
| Common Class I | |||||||||||||
| Common Class S | |||||||||||||
| Total net asset value per common share (in dollars per share) | |||||||||||||
| Total Liabilities and Total Net Assets | |||||||||||||
Loading...
